Seventy-first Regional Committee for Europe: virtual session, 13–15 September 2021: engagement with non-State actors: accreditation and triennial review of regional non-State actors not in official relations with WHO to attend meetings of the WHO Regional Committee for Europe

W OR LD HEALTH OR GAN IZA T I ON R EGIO N AL OFF I C E FOR E U R OPE UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark Telephone: +45 45 33 70 00 Fax: +45 45 33 70 01 Email: eugovernance@who.int Web: http://www.euro.who.int/en/who-we-are/governance Regional Committee for Europe EUR/RC71/15 71st session Virtual session, 13–15 September 2021 2 August 2021 210743 Provisional agenda item 12 ORIGINAL: ENGLISH Engagement with non-State actors: accreditation and triennial review of regional non-State actors not in official relations with WHO to attend meetings of the WHO Regional Committee for Europe This document gives an overview of: • the applications by six non-State actors not in official relations with WHO for accreditation to attend meetings of the WHO Regional Committee for Europe; • the reports submitted by the 19 non-State actors accredited at the 68th session of the Regional Committee for the triennial review of their accreditation status. The Regional Committee is requested to review the applications and the triennial review reports and adopt the related draft decision on this topic at its 71st session. EUR/RC71/15 page 2 Contents Background ................................................................................................................................ 3 Applications for accreditation of regional non-State actors not in official relations with WHO to attend meetings of the Regional Committee ................................................................ 3 Triennial review of collaboration with regional non-State actors not in official relations with WHO accredited to attend meetings of the Regional Committee ...................................... 4 Annex 1. Summary of non-State actors that applied for accreditation status and met the required criteria .......................................................................................................................... 6 Annex 2. Review of three-year engagement with non-State actors accredited in 2018 ............. 9 EUR/RC71/15 page 3 Background 1. Accreditation is a privilege that the WHO Regional Committee for Europe may grant to international, regional and national non-State actors not in official relations with WHO. It includes an invitation to participate, without the right to vote, in meetings of the Regional Committee and the possibility to submit written and oral statements through the WHO Regional Office for Europe (WHO/Europe). 2. To support the Standing Committee of the Regional Committee for Europe (SCRC) and the Regional Committee in fulfilling their mandates on accreditation, the Secretariat assessed applications for accreditation received from non-State actors in 2020 to ensure that all requirements had been fulfilled in accordance with the provisions of the Framework of Engagement with Non-State Actors (FENSA) and resolution EUR/RC67/R7 on Partnerships for health in the WHO European Region. All applicants provided signed tobacco- and arms- related disclosure statements. 3. Furthermore, in accordance with the provisions of FENSA, the Secretariat examined status reports on those non-State actors set to undergo their triennial review after being granted accreditation status at the 68th session of the Regional Committee, 17–20 September 2018. In line with FENSA, due diligence and risk assessments were performed on each non-State actor, and all applicants provided new signed tobacco- and arms-related disclosure statements. As part of this exercise, past collaboration with WHO was assessed, and the jointly agreed plans for collaboration for the coming three years (2021–2024) were examined. Applications for accreditation of regional non-State actors not in official relations with WHO to attend meetings of the Regional Committee 4. Six non-State actors were found to have met the requirements, and the SCRC recommends their accreditation to attend meetings of the Regional Committee. These entities are listed below: • European Association for Palliative Care • European Disability Forum • European Heart Network • European Network for Smoking and Tobacco Prevention • European Society of Cardiology • Mental Health Europe 5. A summary of each non-State actor that applied for accreditation and met the required criteria is available in Annex 1. EUR/RC71/15 page 4 Triennial review of collaboration with regional non-State actors not in official relations with WHO accredited to attend meetings of the Regional Committee 6. In accordance with the provisions of FENSA, the SCRC is requested to review collaboration with each non-State actor accredited to attend the sessions of the Regional Committee every three years and shall make a recommendation to the Regional Committee on whether to maintain accreditation status or to defer the decision to the following year. The SCRC may also recommend that the Regional Committee discontinue accredited status if the SCRC considers that such relations are no longer appropriate or necessary in the light of changing programmes or other circumstances. Similarly, the SCRC may recommend that the Regional Committee suspend or discontinue official relations if an organization no longer meets the criteria that applied at the time of the establishment of such status and fails to update its information or to report on the collaboration to the regional focal points. 7. The review of collaboration with non-State actors during the period 2018–2020 covered 19 entities. The Secretariat has performed due diligence on these entities and has examined their past collaboration and their proposed plans for its continuance. Renewed tobacco- and arms-related disclosure statements were also received. 8. The 19 non-State actors were found to have met the requirements, and the SCRC recommends the renewal of their accreditation status to the Regional Committee. These entities are listed below: • Alzheimer Europe • Association for Medical Education in Europe • Center for Health Policies and Studies • Centre for Regional Policy Research and Cooperation (Studiorum) • Eurocare (European Alcohol Policy Alliance) • EuroHealthNet • European Association for the Study of the Liver • European Cancer Organisation • European Federation of Allergy and Airways Diseases Patients’ Associations • European Federation of the Associations of Dietitians • European Forum for Primary Care • European Forum of Medical Associations • European Forum of National Nursing and Midwifery Associations • European Medical Students’ Association • European Public Health Alliance • European Public Health Association • Health Care Without Harm EUR/RC71/15 page 5 • Standing Committee of European Doctors • Wemos 9. A brief summary of the past three years of collaboration (2018–2020) and proposed future three-year plans (2021–2024) for each of the 19 entities is included in Annex 2. 10. The Regional Committee is invited to adopt the draft decision on this topic. EUR/RC71/15 page 6 Annex 1. Summary of non-State actors that applied for accreditation status and met the required criteria European Association for Palliative Care 1. The European Association for Palliative Care (EAPC) is a registered non-profit organization in Belgium that aims to advance, influence, promote and develop palliative care in Europe. EAPC has 60 national member associations from 33 countries and individual members from 59 countries globally. It is governed by an annual general assembly, where issues are raised and agreed on by the membership. The association receives funding from a combination of membership fees, European Union (EU) research funding and congress registration fees. 2. Planned collaborative activities with the WHO Regional Office for Europe (WHO/Europe) in 2021–2024: EAPC has agreed to a joint three-year workplan that includes contributing to the following areas: ensuring access to essential medicines used in palliative care for pain and symptom management, ensuring that palliative care is a part of universal health coverage, ensuring that palliative care is included in WHO policies, and acknowledging the essential role of palliative care in the response to COVID-19. European Disability Forum 3. The European Disability Forum (EDF) is a non-profit umbrella organization of persons with disabilities that defends the interests of over 100 million persons with disabilities in Europe. It is governed through the annual general assembly (full and ordinary member organizations); a president; membership, finance and credential committees; advisory bodies; and the board of directors. EDF is committed to financial transparency, and in 2018 its annual budget was approximately €1.8 million, with around 70% provided by the EU and 30% provided by a combination of other donors and partners. 4. Planned collaborative activities with WHO/Europe in 2021–2024: EDF has previously cooperated with WHO/Europe in various ways and hopes to continue this collaboration in the next three years with the technical unit and focal point, in particular through advocacy on health, disability and rehabilitation. There are also plans for a project to create inclusive and accessible health materials. In this joint project, EDF will develop a series of materials focusing on the inclusion of persons with disabilities in the response to COVID-19. EDF also plans to focus on COVID-19 prevention, access to health services and rehabilitation. European Heart Network 5. The European Heart Network (EHN) is a non-profit association, established under Belgian law, dedicated to fighting heart disease and stroke and supporting patients throughout Europe. EHN was formally established in 1992 at a meeting in Lisbon, Portugal, by 12 organizations from nine countries. It now has 28 members from 23 European countries. It is governed by a general assembly, which comprises all the members of EHN. 6. EHN establishes multiannual financial plans that determine the annual funding needs for EHN during the term. The core costs are fully funded by the members, all of whom pay annual contributions. Contributions are calculated on the basis of each member’s ability to EUR/RC71/15 page 7 pay. EHN has also obtained funding from the EU for large-scale projects that EHN has led, as well as for projects in which EHN has been a partner. 7. Planned collaborative activities with WHO/Europe in 2021–2024: EHN has a longstanding working relationship with WHO/Europe. The application contains an overview of engagement in 2018 and 2019. Furthermore, EHN and WHO/Europe have agreed to a joint three-year workplan that includes the following areas: prioritizing primary prevention of cardiovascular disease; preventing avoidable cardiovascular disease; providing better patient care through improved diagnosis, treatment and management; and building capacity and strengthening EHN. European Network for Smoking and Tobacco Prevention 8. The European Network for Smoking and Tobacco Prevention (ENSP) is an international not-for-profit organization that aims to put an end to tobacco consumption and to develop a common strategy among organizations active in smoking prevention and tobacco control in Europe by sharing information and experience and through coordinated activities and projects. The highest priority objective is to have the Roadmap of actions to strengthen implementation of the WHO Framework Convention on Tobacco Control in the European Region 2015–2025 fully implemented and enforced in all countries in the WHO European Region to reduce the prevalence of tobacco use in Europe to less than 5% by 2040. With more than 60 full members, including national coalitions, present in 34 European countries (20 EU and 14 non-EU), ENSP is the only European network involving national coalitions working at the national (and sometimes local) level, as well as at the European level, for a comprehensive and thorough approach to tobacco control. Funding sources in 2019 included membership fees (€29 177), EU operating and project grants (€546 055), the ENSP annual conference (€81 049), and other external income and project grants (€93 936). 9. Planned collaborative activities with WHO/Europe in 2021–2024: ENSP will continue its previous course of engagement with WHO/Europe in the coming years, but will focus on introducing a more comprehensive approach by integrating tobacco control into the wider picture of sustainable development, protecting human rights, empowering younger generations, and creating an overall healthier future for Europe through prevention activities and education on the negative effects of tobacco. ENSP would like to strengthen relations with the WHO Representation to the European Union in Brussels, Belgium. European Society of Cardiology 10. The European Society of Cardiology (ESC) is a not-for-profit organization registered in France. ESC is a health care professionals’ organization, bringing together around 100 000 experts in cardiovascular science from 57 countries in Europe. It produces and disseminates scientific knowledge on reducing the burden of cardiovascular disease. ESC is governed by an elected board of volunteer cardiovascular experts, and its activities are overseen by several committees, comprising over 2000 cardiology expert volunteers. A number of ESC activities raise funds, such as congresses, journals and membership. 11. Planned collaborative activities with WHO/Europe in 2021–2024: ESC has worked collaboratively with WHO/Europe for several years and the two organizations have discussed and agreed to a joint three-year workplan that includes the following areas: participation (for EUR/RC71/15 page 8 example, attending meetings organized by WHO/Europe, including meetings of the governing bodies, consultations, hearings and other meetings), advocacy (for example, joint advocacy initiatives such as country case studies and joint publications in ESC journals), and technical collaboration (for example, product development, capacity-building, operational collaboration in emergencies, and contributions to the implementation of WHO/Europe’s policies). Mental Health Europe 12. Mental Health Europe (MHE) is a non-profit association, registered in Belgium, committed to the promotion of positive mental health; prevention of mental distress; improvement of care; advocacy for social inclusion; and protection of the rights of users and ex- users of mental health services, persons with psychosocial disabilities, and their families and carers. MHE has a fully democratic structure and governance system, with a board, executive committee and general assembly as its key governing bodies. The MHE board of directors is elected for two years and currently has 15 members from 15 European countries. MHE’s annual activity report for 2019 provides a detailed overview of the annual income sources of the organization, including EU and institutional funding, membership fees and donations. 13. Planned collaborative activities with WHO/Europe in 2021–2024: MHE has worked collaboratively with WHO/Europe for several years, and the two organizations have discussed and agreed to a joint three-year workplan, primarily focused on contributing to the objectives of the European Programme of Work, 2020–2025, and the global Mental Health Action Plan 2013–2020, now extended to 2030. The workplan also focuses on WHO/Europe’s Mental Health Coalition flagship initiative. EUR/RC71/15 page 9 Annex 2. Review of three-year engagement with non-State actors accredited in 2018 Alzheimer Europe 1. Collaborative activities with the WHO Regional Office for Europe (WHO/Europe) in 2018–2020: Alzheimer Europe has engaged extensively with WHO/Europe as well as WHO headquarters, seeking to share information, promote the work of WHO and WHO/Europe on dementia and ensure the engagement of WHO and WHO/Europe at relevant policy forums at the European Union (EU) level. This work has included ensuring the participation of WHO and WHO/Europe in meetings of the European Group of Governmental Experts on Dementia (a Europe-wide forum for European dementia policy leads from health or social affairs ministries) and promoting the work of WHO and WHO/Europe in Alzheimer Europe’s print and online reporting (newsletters, magazines, etc.). 2. Examples of planned engagement for 2021–2024: Alzheimer Europe will seek to engage with WHO/Europe as it has in recent years, involving it in key policy dialogues about dementia at the EU level (for example, through the European Group of Governmental Experts on Dementia) and promoting WHO’s work, particularly in relation to the Global action plan on the public health response to dementia 2017–2025. Alzheimer Europe will seek to step up its engagement, particularly in relation to the prioritization of dementia as a focus for the work of WHO/Europe. The action plan falls under the Mental Health Coalition flagship initiative, as set out in the WHO European Programme of Work, 2020–2025 (EPW). As such, Alzheimer Europe will seek to work constructively with WHO/Europe to ensure that dementia is given due attention and focus as part of this programme. Association for Medical Education in Europe 3. Collaborative activities with WHO/Europe in 2018–2020: the Association for Medical Education in Europe (AMEE) has been working closely with and promoting the aims of WHO/Europe since being accredited. An example of the type of activity being undertaken includes organizing the AMEE Europe session during the AMEE 2019 world conference in Vienna. The opening speaker for this session was a WHO/Europe representative, and the aim of this session was to introduce WHO/Europe as the main stakeholder in European health workforce education. This session was organized for leaders of European health professional education organizations and institutions. 4. Examples of planned engagement for 2021–2024: AMEE will continue working closely with WHO/Europe, as it has done in recent years, participating in joint meetings and advocacy. For example, there is an established and bilaterally agreed plan to continue organizing WHO sessions during AMEE conferences (which usually have approximately 4000 participants). Center for Health Policies and Studies 5. Collaborative activities with WHO/Europe in 2018–2020: the Center for Health Policies and Studies continued work within the Tuberculosis Regional Eastern European and Central Asian Project (TB-REP) on replicating good practices of people-centred models of tuberculosis (TB) care across eastern European and central Asian countries. The Center for EUR/RC71/15 page 10 Health Policies and Studies also worked on the preparation of the 2020 annual meeting of the Regional Collaborating Committee on Accelerated Response to Tuberculosis, HIV and Viral Hepatitis, cofacilitated the working group session and presented during the panel session “Ensuring continuity of TB services during COVID-19”. 6. Examples of planned engagement for 2021–2024: within the TB-REP 2.0 project (2018–2021), the Center for Health Policies and Studies and WHO/Europe will continue to cooperate in accordance with the project arrangements and foster timely TB case detection and improved treatment outcomes. They will achieve this through meaningful involvement of communities and civil society and through integrated people-centred TB care delivery systems able to address the needs of key and vulnerable populations. Centre for Regional Policy Research and Cooperation (Studiorum) 7. Collaborative activities with WHO/Europe in 2018–2020: Studiorum participated in joint meetings and the development of an evidence brief for policy for the WHO Evidence- informed Policy Network Europe policy series. 8. Examples of planned engagement for 2021–2024: for the next three-year period, Studiorum plans to further collaborate with WHO/Europe in the area of antimicrobial resistance. In addition, Studiorum intends to expand its collaboration with WHO/Europe throughout its networks, bidirectionally, by promoting the work of WHO/Europe and sourcing information and expertise from its networks to feed back into the collaboration. Eurocare (European Alcohol Policy Alliance) 9. Collaborative activities with WHO/Europe in 2018–2020: Eurocare’s collaboration has involved regularly speaking at and participating in WHO/Europe meetings and cohosting joint meetings, such as when Eurocare – together with its member Scottish Health Action on Alcohol Problems – hosted a WHO regional meeting with alcohol policy experts and Member State representatives. 10. Examples of planned engagement for 2021–2024: Eurocare is planning for activities during the ninth European Awareness Week on Alcohol-Related Harm, which will take place in November 2021, in collaboration with WHO/Europe and Awareness Week partners. Furthermore, Eurocare will provide input and support to the ongoing discussions between WHO headquarters and Codex Alimentarius in 2021. EuroHealthNet 11. Collaborative activities with WHO/Europe in 2018–2020: EuroHealthNet has a long history of engagement and collaboration with WHO/Europe and has continued this active engagement via exchanges of information and experiences, mutual support and collaboration in relation to policy, advocacy, dissemination, research and country-level capacity-building. One of the biggest achievements of this collaboration was the joint conceptualization of an e-guide for financing health-promoting services, supported by the WHO Coalition of Partners. 12. Examples of planned engagement for 2021–2024: specific areas that have already been identified as opportunities for collaboration to be explored in a potential memorandum of EUR/RC71/15 page 11 understanding include intelligence and information sharing; capacity-building in countries, regions and localities with agencies and networks in the context of the EPW and EuroHealthNet work programme; strengthening of EuroHealthNet links with WHO offices, centres and networks, notably the geographically dispersed offices in Moscow, Russian Federation and Venice, Italy, and the WHO Representation to the European Union, Brussels, Belgium office; participation of EuroHealthNet in the four newly agreed WHO/Europe flagship initiatives, particularly the Mental Health Coalition and the Healthier behaviours: incorporating behavioural and cultural insights initiatives; and involvement of EuroHealthNet with the new Pan-European Transformational Leadership Academy. European Association for the Study of the Liver 13. Collaborative activities with WHO/Europe in 2018–2020: every year at the International Liver Congress, the European Association for the Study of the Liver (EASL) organizes public health sessions that address pressing issues from a more societal perspective. EASL worked with WHO/Europe on viral hepatitis sessions for a number of years. In 2019, a WHO–EASL special symposium was organized on best practices and lessons learned from global viral hepatitis scale-up. The symposium shared key findings, with presentations on four selected good practice topics, including country examples. 14. Examples of planned engagement for 2021–2024: EASL is planning to launch, with WHO/Europe as a partner, a Healthy Liver Day, in support of one of the flagship initiatives of the EPW: Healthier behaviours: incorporating behavioural and cultural insights. The Healthy Liver Day will promote behaviours related to healthy lifestyles (such as recommendations on healthy diet, including reduced alcohol consumption). European Cancer Organisation 15. Collaborative activities with WHO/Europe in 2018–2020: examples of collaboration with WHO/Europe include active contributions to WHO/Europe consultations; participation in WHO/Europe events, including WHO Regional Committee for Europe meetings; promotion of WHO/Europe outputs including publications; and involvement of WHO/Europe in principal events of the European Cancer Organisation (ECCO), including the European Cancer Summit. 16. Examples of planned engagement for 2021–2024: ECCO would like to further involve WHO/Europe in the convening activities of its special networks, including those on COVID-19, inequalities, workforce, and human papillomavirus cancer elimination and prevention, all of which have much relevance to the EPW. European Federation of Allergy and Airways Diseases Patients’ Associations 17. Collaborative activities with WHO/Europe in 2018–2020: the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) participated in events organized by WHO/Europe, for example, the Joint Convention/WHO Task Force on the Health Aspects of Long-range Transboundary Air Pollution and the open consultation on the EPW organized by WHO/Europe in August 2020. EUR/RC71/15 page 12 18. Examples of planned engagement for 2021–2024: EFA plans to engage with WHO/Europe on a wide range of issues, including improved access to high-quality health services from prevention and diagnosis to treatment and care, and to assist with the communication of the upcoming revised WHO Air Quality Guidelines by reviewing communication tools and materials addressed to vulnerable groups and by promoting evidence-based information within EFA channels. European Federation of the Associations of Dietitians 19. Collaborative activities with WHO/Europe in 2018–2020: the European Federation of the Associations of Dietitians (EFAD) has been involved with relevant WHO/Europe conferences and meetings and has supported and engaged with projects and surveys. For example, EFAD invited the WHO Regional Director for Europe to address EFAD’s Annual General Meeting, “Better food and diets for better health – a centrepiece of the WHO European Programme of Work”, in October 2020. 20. Examples of planned engagement for 2021–2024: to achieve the goals of the EPW, EFAD plans to support WHO/Europe in introducing the profession of dietetics into the entire WHO European Region. EFAD has, together with the profession, developed and adopted European standards for the education and training of dietitians and for their continued professional development and lifelong learning, and plans to start with a mapping exercise and to launch online learning opportunities for dietitians. European Forum for Primary Care 21. Collaborative activities with WHO/Europe in 2018–2020: the European Forum for Primary Care (EFPC) has been involved with relevant WHO/Europe conferences and activities, in particular in collaboration with the WHO European Centre for Primary Health Care in Almaty, Kazakhstan. EFPC has been particularly active at the country level in Kazakhstan, Romania and Ukraine. 22. Examples of planned engagement for 2021–2024: EFPC’s plans for this period include increased collaboration with the WHO European Centre for Primary Health Care, Almaty, Kazakhstan, on the development of primary health care in Europe, based on the input of EFPC’s members and international allies. This should result in joint activities such as webinars, workshops and presentations on subthemes related to primary health care. European Forum of Medical Associations 23. Collaborative activities with WHO/Europe in 2018–2020: WHO/Europe has been involved in the annual European Forum of Medical Associations (EFMA) meeting and joint projects. For example, each year EFMA holds an annual meeting and contacts the WHO office in the hosting country to assist EFMA in identifying topics that would be of interest to the host country. 24. Examples of planned engagement for 2021–2024: EFMA will continue to involve WHO/Europe in its virtual meetings for 2021, one of which (on fighting pandemics) took place in June 2021, and the potential in-person meeting due to be held in Ukraine at the end of the year. EFMA will consult with colleagues from WHO/Europe including country offices to EUR/RC71/15 page 13 decide on topics for its meetings. EFMA is preparing a proposal for WHO/Europe to collaborate in gaining greater understanding of the implications for health care professionals of the current pandemic. A detailed proposal will be submitted to WHO/Europe. European Forum of National Nursing and Midwifery Associations 25. Collaborative activities with WHO/Europe in 2018–2020: the European Forum of National Nursing and Midwifery Associations (EFNNMA) advocated, disseminated and promoted the European strategic directions for strengthening nursing and midwifery in the context of Health 2020: the European policy for health and well-being, at country level through professional networks, meetings and other channels to raise awareness and encourage commitments. This work has included participating in joint meetings and providing regular news stories in relation to the International Day of the Nurse. 26. Examples of planned engagement for 2021–2024: EFNNMA plans on continuing its already strong partnership with WHO/Europe by developing and supporting activities on leadership in nursing and midwifery and strengthening the work on dissemination of best practices, as well as collecting successful nurse- and midwife-led models of care. EFNNMA will also participate in the sessions of the Regional Committee and provide statements on issues relevant for nursing and midwifery, and in other relevant high-level technical meetings with WHO/Europe. European Medical Students’ Association 27. Collaborative activities with WHO/Europe in 2018–2020: the European Medical Students’ Association (EMSA) attended the Regional Committee meetings in 2018 and 2019, as well as the virtual meeting in 2020. EMSA actively participated in discussions, provided feedback on documents and read out statements representing European medical students’ viewpoints on various issues. Further collaborative efforts have mostly been focused on digital health. 28. Examples of planned engagement for 2021–2024: EMSA plans on better integrating its collaboration with WHO/Europe into the planning of its work and activities. This will enable EMSA’s members and board to take greater advantage of the benefits EMSA gains through the partnership, but will also help EMSA support WHO/Europe more in its work. Specifically, in light of the ongoing COVID-19 pandemic, EMSA has started to work more intensively on the topic of vaccine hesitancy. European Public Health Alliance 29. Collaborative activities with WHO/Europe in 2018–2020: as a member of the WHO/Europe Coalition of Partners, the European Public Health Alliance (EPHA) shared its perspective with national and regional actors and other civil society stakeholders at workshops held at WHO/Europe’s main office in Copenhagen, Denmark in 2018–2019. Also, between 2018 and 2020, EPHA coordinated nongovernmental organization dialogue with the WHO Representation to the European Union, Brussels, Belgium office to exchange views with civil society (EU advocacy and global health nongovernmental organizations), which included a number of meetings at the EPHA office. EUR/RC71/15 page 14 30. Examples of planned engagement for 2021–2024: EPHA is keen to be an active implementing partner for the EPW and its flagship initiatives. EPHA will be seeking follow- up meetings with the WHO Regional Director for Europe, and other senior programme leads to determine how it can most effectively contribute to the success of the EPW. European Public Health Association 31. Collaborative activities with WHO/Europe in 2018–2020: as well as participating in joint meetings and initiatives, the three main tools of the European Public Health Association (EUPHA) – the European Journal of Public Health, the European Public Health Conference and the newsletter – have all been used to inform EUPHA membership about WHO/Europe activities as well as to offer WHO/Europe different platforms to present its activities. 32. Examples of planned engagement for 2021–2024: over the next three years, EUPHA will continue to disseminate WHO information in its newsletter and will continue its collaboration with WHO/Europe through European Public Health News. EUPHA will also continue to offer other dissemination tools and send expert representatives to all high-level meetings. Health Care Without Harm 33. Collaborative activities with WHO/Europe in 2018–2020: Health Care Without Harm (HCWH) Europe attended the Regional Committee meetings, making a number of joint statements with other non-State actors, and provided a comprehensive response to the open written consultation on the EPW. The organization has also strengthened relations with the WHO European Centre for Environment and Health in Bonn, Germany, and was invited to speak at the Working Group on Health in Climate Change meeting in December 2020. 34. Examples of planned engagement for 2021–2024: HCWH Europe plans to continue to engage with the European Centre for Environment and Health, as well as the European Environment and Health Task Force, particularly as HCWH looks to engage with national ministries of health and WHO/Europe in relation to its Operation Zero initiative. The organization also plans to continue actively participating in future sessions of the Regional Committee and support implementation of the EPW across all of its core priorities. Standing Committee of European Doctors 35. Collaborative activities with WHO/Europe in 2018–2020: as well as regular attendance and participation in the Regional Committee meetings, the Standing Committee of European Doctors (CPME) has provided continuous collaboration on topics in the Framework of Engagement with Non-State Actors workplan, maintaining exchanges on activities relating to antimicrobial resistance, alcohol, vaccination and healthy workforce policy, and disseminating information and outcomes of WHO/Europe processes to CPME members. 36. Examples of planned engagement for 2021–2024: CPME plans to contribute to the implementation of the EPW in relation to health workforce, vaccinations, antimicrobial resistance and digital health and to continue discussions on a joint event in the European Parliament on health professions and pandemic management. EUR/RC71/15 page 15 Wemos 37. Collaborative activities with WHO/Europe in 2018–2020: a recent example of collaboration with WHO/Europe is from 2020, when Wemos liaised with WHO/Europe’s Human Resources for Health Programme in relation to two (separate but complementary) funding proposals that Wemos was developing for European-level work: one on health worker mobility in Europe and the need to mitigate the negative consequences of this mobility (funded by Open Society Foundations); and the other on medical deserts and the need for health workforce reforms (funded by the European Commission’s Consumers, Health, Agriculture and Food Executive Agency). 38. Examples of planned engagement for 2021–2024: over the next three years, Wemos expects to regularly share new knowledge and information – for example, specific country analyses on medical deserts and their root causes – and potential policy solutions for health workforce challenges with WHO/Europe. Wemos will also invite WHO/Europe to specific events and webinars it organizes and participate in regular bilateral meetings to align their work with that of WHO/Europe to the best possible extent. = = =